5.2 Peptide-involved epigenomic therapy The peptide ST101 functions as a potent inhibitor of C/EBP (CCAAT/enhancer binding protein ), a basic leucine zipper (bZIP) transcription factor frequently upregulated or overactivated in numerous cancers (Portale et al., 2024)
Discussion The clinical management of patients with type 2 diabetes has to balance the potential benefits of controlling hyperglycemia on microvascular and macrovascular complications, [11] with possible side effects of treatment and possible harm from over intensive control of glycemia
Helps in the reduction of cancer cells in the body: Glutathione reduces the chances of chemotherapy in cancer patients and it prevents the cancer from spreading by repairing and regenerating the cells to reduce the tumour
By bypassing the digestive system, this therapy allows for higher therapeutic doses without gastrointestinal side effects, helping patients feel revitalized, supported, and rebalanced more quickly than oral supplementation alone
This action helps people with type 2 diabetes control their blood sugar more effectively
)
/assets/images/provider/photos/2775923.jpeg)
